Ready to pay "reasonable" royalty to Novartis AG: Cipla to HC
Indian pharma firm Cipla Monday suggested to the Delhi High Court that it was ready to pay "reasonable" royalty to Switzerland-based drug major Novartis AG if it is allowed to manufacture respiratory disease drug, 'Indaflo', which could serve 66,000 patients in India at a cheaper rate.
Apr 27, 2015, 23:21 PM IST
Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma
The company was clarifying on speculations that Sanghvi, who holds 9.61 percent stake in Sun Pharma, had bought shares when Daiichi Sankyo exited from the Indian firm.
Apr 22, 2015, 12:04 PM IST
Fund raising plans lift Glenmark shares by over 4%
Shares of Glenmark Pharmaceuticals went up by over 4 percent Monday as it plans to raise up to Rs 945 crore by issuing over one crore shares to Temasek Holdings, the investment arm of Singapore government, on a preferential basis.
Apr 20, 2015, 21:54 PM IST
Daiichi Sankyo to offload stake in Sun Pharma worth Rs 22,000 cr
Japanese drug maker Daiichi Sankyo Monday said it board has approved selling a part or entire 9 percent holding worth over Rs 22,000 crore in Indian drug major Sun Pharmaceutical.
Apr 20, 2015, 18:53 PM IST
Pharma shares fall; Sun Pharma top loser on Sensex
Pharma shares fell by up to 3.6 percent Thursday amid reports that global brokerage firm Bank of America Merrill Lynch has downgraded some of the drug firms.
Apr 09, 2015, 21:45 PM IST
Plethico shares soar 20% on settlement pact with Aurobindo
Shares of Plethico Pharmaceuticals zoomed 20 percent Thursday after reaching settlement with Aurobindo Pharma related to the acquisition of US-based Natrol.
Apr 09, 2015, 20:03 PM IST
Govt aims to raise domestic medical devices industry to $50 bn
Government is aiming to increase the size of domestic medical devices sector to USD 50 billion by taking of a slew of measures, including setting up of two parks, Fertiliser Minister Ananth Kumar said Wednesday.
Apr 08, 2015, 22:01 PM IST
CCEA clears Glenmark, Aurobindo proposals worth Rs 4,187 cr
Pharmaceutical majors Glenmark and Aurobindo's foreign investment proposals, worth Rs 4,187 crore, were approved by the government Tuesday.
Apr 07, 2015, 21:49 PM IST
'Dr Reddy's in talks to buy UCB India business for $135 million'
Drugmaker Dr Reddy`s Laboratories Ltd is in talks to acquire the Indian operations of Belgian pharmaceutical company UCB SA for about $135 million, said a person with direct knowledge of the matter.
Mar 10, 2015, 19:34 PM IST
HC allows merger of Ranbaxy and Sun pharma
The Punjab and Haryana High Court Monday gave its nod to the merger of two Indian pharmaceutical companies - Ranbaxy Laboratories Limited with Sun Pharmaceutical Industries Limited.
Mar 09, 2015, 23:00 PM IST
Ranbaxy's global HR head Udbhav Ganjoo quits
Ranbaxy Laboratories Global Head of Human Resources Udbhav Ganjoo has resigned from the company and may join multinational pharmaceutical firm Mylan.
Mar 02, 2015, 19:56 PM IST
Biocon to invest 10% of biopharma revenues on R&D next fiscal
Continuing it emphasis on innovation, biotechnology major Biocon plans to spend 10 percent of its annual biopharma revenue on research and development in the next fiscal year.
Feb 01, 2015, 20:27 PM IST
Sun Pharma-Ranbaxy deal: US FTC asks Ranbaxy to divest asset
After Competition Commission of India, US fair trade watchdog FTC has asked Ranbaxy to divest one generic product as a condition for clearing its USD 4 billion deal with Sun Pharma to address monopoly concerns.
Jan 31, 2015, 13:03 PM IST
Govt allows Lupin to hike FII limit cap to 49%
The government Wednesday allowed drug maker Lupin to raise the cap of foreign institutional investor holding to 49 percent, a move that would facilitate an inflow of Rs 6,099 crore.
Jan 28, 2015, 21:08 PM IST
India wants its officials during FDA inspections at drug units
Perturbed by Indian drug-makers frequently running into overseas regulatory problems, the government has requested the US health watchdog FDA to allow its officials during inspections of domestic pharma units.
Jan 11, 2015, 12:13 PM IST
Lupin eyes acquisitions in US, Europe
Drug major Lupin is eyeing acquisitions in various global markets, including the US, Latin America and Europe, as it looks to bolster its presence overseas.
Dec 28, 2014, 13:56 PM IST
Kumar calls for policy, regulation shift in Pharma sector
Calling for a shift in policy and regulation in pharma sector, government Tuesday stressed on the need for pharma industry to make quality medicines available to public at affordable rates.
Dec 23, 2014, 20:57 PM IST
CCI clears multi-billion Novartis-GSK pharma deal
Fair trade regulator CCI has approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis, as it did not find the transaction to be anti-competitive ion India.
Dec 23, 2014, 20:07 PM IST
Ranbaxy Lab, Sun Pharma gain as CCI clears deal
Ranbaxy Lab's stock rose 4 percent to Rs 650.7 at the BSE.
Dec 09, 2014, 13:14 PM IST
CCI clears Sun-Ranbaxy deal with riders; asks to divest 7 products
The approval, which comes within days of clearance from theFIPB, for the deal that was announced in April and would create create India's largest and world's fifth biggest drug-maker.
Dec 08, 2014, 18:23 PM IST
